Applied DNA Sciences, Inc. Total Assets
Applied DNA Sciences, Inc. total assets. Based on the latest financial reports, Applied DNA Sciences, Inc. (BNBX) holds total assets worth $13.63 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market cap of Applied DNA Sciences, Inc. for the company's overall valuation and market capitalisation.
Total Assets of Applied DNA Sciences, Inc. (2021–2025)
Total assets of Applied DNA Sciences, Inc. from 2021 to 2025. This chart illustrates how Applied DNA Sciences, Inc.'s total assets have evolved over time, based on quarterly financial data. See current stock price of Applied DNA Sciences, Inc. for real-time trading data and today's change.
Applied DNA Sciences, Inc. - Asset Composition Analysis
Applied DNA Sciences, Inc. Total Assets Breakdown (September 2025)
Applied DNA Sciences, Inc. total assets breakdown as of September 2025. Applied DNA Sciences, Inc.'s total assets of $13.63 Million consist of 50.4% current assets and 49.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 37.6% |
| Accounts Receivable | $237.40K | 5.4% |
| Inventory | $84.10K | 1.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Applied DNA Sciences, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Applied DNA Sciences, Inc. to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Applied DNA Sciences, Inc.'s current assets represent 50.4% of total assets in 2025, a decrease from 78.4% in 2021.
- Cash Position: Cash and equivalents constituted 37.6% of total assets in 2025, down from 45.5% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 5.4% of total assets.
Applied DNA Sciences, Inc. Competitors by Total Assets
Key competitors of Applied DNA Sciences, Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bajaj Holdings & Investment Limited
NSE:BAJAJHLDNG
|
India | Rs851.87 Billion |
|
RiverNorth Flexible Municipal Income Fund II Inc
NYSE:RFMZ
|
USA | $585.45 Million |
|
IGM Financial Inc.
TO:IGM
|
Canada | CA$21.78 Billion |
|
Groep Brussel Lambert NV
BR:GBLB
|
Belgium | €25.06 Billion |
|
Sprott Physical Gold and Silver Trust
TO:CEF
|
Canada | CA$9.34 Billion |
|
Australian Foundation Investment Company Ltd
AU:AFI
|
Australia | AU$9.82 Billion |
|
Golub Capital BDC Inc
NASDAQ:GBDC
|
USA | $8.98 Billion |
|
CI Financial Corp
TO:CIX
|
Canada | CA$11.01 Billion |
Applied DNA Sciences, Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.82 | 4.45 | 3.91 |
| Quick Ratio | 1.74 | 4.27 | 3.76 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.21 Million | $6.54 Million | $8.82 Million |
Applied DNA Sciences, Inc. - Advanced Valuation Insights
This section examines the relationship between Applied DNA Sciences, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.10 |
| Latest Market Cap to Assets Ratio | 0.21 |
| Asset Growth Rate (YoY) | -65.3% |
| Total Assets | $4.44 Million |
| Market Capitalization | $929.58K USD |
Valuation Analysis
Below Book Valuation: The market values Applied DNA Sciences, Inc.'s assets below their book value (0.21x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Applied DNA Sciences, Inc.'s assets decreased by 65.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Applied DNA Sciences, Inc. (2021–2025)
The table below shows the annual total assets of Applied DNA Sciences, Inc. from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $4.44 Million | -65.30% |
| 2024-09-30 | $12.79 Million | -6.32% |
| 2023-09-30 | $13.65 Million | -38.69% |
| 2022-09-30 | $22.27 Million | +54.44% |
| 2021-09-30 | $14.42 Million | -- |
About Applied DNA Sciences, Inc.
BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic m… Read more